Zimmer Biomet Holdings, Inc. has announced that the U.S. Food and Drug Administration (FDA) granted ‘Breakthrough Device Designation’ for its new iodine…….
On October 24, 2025, the U.S. Food & Drug Administration (FDA) approved Lynkuet, a once-daily, non-hormonal capsule for the treatment of moderate-to-severe…..